VANI Financials Vivani Medical, Inc.
13 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $0 | $27M | — | — | -$25M | — | $16M |
| 2024 | $0 | $23M | — | — | -$21M | — | $18M |
| 2023 | — | $26M | — | — | -$25M | — | $21M |
| 2022 | — | -$14M | — | — | -$19M | — | $45M |
| 2021 | — | -$13M | — | — | -$12M | — | $2M |
| 2020 | — | -$15M | — | — | -$17M | — | $2M |
| 2019 | $3M | -$34M | 36.3% | -1004.9% | -$28M | — | $11M |
| 2018 | $7M | -$35M | 29.1% | -509.9% | -$30M | — | $4M |
| 2017 | $8M | -$29M | 35.7% | -359.2% | -$24M | — | $8M |
| 2016 | $4M | -$33M | -152.8% | -833.4% | -$26M | — | $11M |
| 2015 | — | -$20M | — | — | -$21M | — | $16M |
| 2014 | — | -$35M | — | — | — | — | $619 |
| 2013 | — | -$23M | — | — | — | — | $62000 |
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | -$7M | — | — | -$6M | — | $20M |
| Dec '25 | — | -$7M | — | — | -$7M | — | $16M |
| Sep '25 | — | -$7M | — | — | -$7M | — | $3M |
| Jun '25 | $0 | -$7M | — | — | -$6M | — | $7M |
| Mar '25 | $0 | -$6M | — | — | -$5M | — | $13M |
| Dec '24 | $0 | -$6M | — | — | -$6M | — | $18M |
| Sep '24 | $0 | -$6M | — | — | -$6M | — | $20M |
| Jun '24 | — | -$5M | — | — | -$5M | — | $25M |
| Mar '24 | — | -$6M | — | — | -$5M | — | $30M |
| Dec '23 | — | -$6M | — | — | -$4M | — | $21M |
| Sep '23 | — | -$7M | — | — | -$8M | — | $25M |
| Jun '23 | — | -$7M | — | — | -$6M | — | $32M |
| Mar '23 | — | -$6M | — | — | -$7M | — | $38M |
| Dec '22 | — | -$7M | — | — | -$5M | — | $45M |
| Sep '22 | — | $1M | — | — | -$7M | — | $52M |
| Jun '22 | — | -$4M | — | — | -$4M | — | $56M |
| Mar '22 | — | -$4M | — | — | -$3M | — | $60M |
| Dec '21 | — | -$4M | — | — | -$3M | — | $2M |
| Sep '21 | — | -$3M | — | — | — | — | $1M |
| Jun '21 | $0 | -$3M | — | — | — | — | $74M |
Valuation over time
How the market has priced VANI against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 3.6× (Jan '24) to 3.7× (Jun '26).
Frequently asked questions
Is VANI growing its revenue and profit?
See the revenue and net-income charts above for Vivani Medical, Inc.'s multi-year trend.
How much debt does VANI have?
As of FY2025, Vivani Medical, Inc. reported — of total debt against $16M of cash.
What is VANI's profit margin?
In FY2025, gross margin was —, operating margin —, and net margin —.
What is VANI's P/E ratio?
As of Jun '26, Vivani Medical, Inc. traded at a price-to-earnings ratio of about 3.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.